DF
Daniel Friedman
OtherActiveVice President at BroadOak Capital Partners
11
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Daniel Friedman.
Investment Thesis & Strategy
BroadOak Capital Partners, with Daniel Friedman as Vice President, invests across various stages in biotech and fintech companies. They seek to partner with innovative companies in these sectors to drive growth and generate returns.
Investment Activity
Deals per year over the last 15 years
1
20000
20010
20020
20030
20041
20051
20060
20072
20080
20091
20101
20110
20121
20132
2014Portfolio Companies
Selected investments from their portfolio of 11 companies
B
Bioinformatics
Biotech · Seed, 0
C
Codex DNA
Biotech · Series B, 2014
G
Genomenon
Biotech · Series B, 2014
s
seqWell
Biotech · Series A, 2013
H
Halo Labs
Biotech · Series B, 2011
I
InFuse Holdings
Biotech · Seed, 2010
B
BioCision
Biotech · Series A, 2008
D
Diagnostic BioSystems
Biotech · Seed, 2008
E
Empire Genomics
Biotech · Seed, 2006
L
LabConnect
Healthcare · Growth, 2005
R
Rubicon Genomics
Biotech · Series A, 2000
Frequently Asked Questions
Daniel Friedman invests across multiple stages. Sign up to view detailed stage data.